Zeo ScientifiX Files 8-K
Ticker: ZEOX · Form: 8-K · Filed: Nov 13, 2024 · CIK: 1557376
Sentiment: neutral
Topics: regulatory-filing, company-update
TL;DR
Zeo ScientifiX filed an 8-K, likely containing routine updates or financial info.
AI Summary
Zeo ScientifiX, Inc. filed an 8-K on November 13, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Organicell Regenerative Medicine, Inc., is incorporated in Nevada and has its principal executive offices in Davie, Florida. This filing does not contain specific financial figures or event details beyond its classification.
Why It Matters
This 8-K filing indicates that Zeo ScientifiX, Inc. has made a regulatory submission to the SEC, which may contain important updates or disclosures for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K without immediate negative or positive financial disclosures, suggesting low immediate risk.
Key Players & Entities
- Zeo ScientifiX, Inc. (company) — Registrant
- Organicell Regenerative Medicine, Inc. (company) — Former company name
- November 13, 2024 (date) — Date of report
- Nevada (jurisdiction) — State of incorporation
- Davie, Florida (location) — Business address
FAQ
What specific event triggered this 8-K filing?
The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits,' but the specific triggering event is not detailed in the provided text.
What was Zeo ScientifiX, Inc. previously named?
Zeo ScientifiX, Inc. was formerly known as Organicell Regenerative Medicine, Inc., and prior to that, Biotech Products Services & Research, Inc., and Bespoke Tricycles Inc.
Where is Zeo ScientifiX, Inc. headquartered?
Zeo ScientifiX, Inc.'s business and mailing address is 3321 College Avenue, Suite 246, Davie, Florida.
When did Zeo ScientifiX, Inc. change its name from Organicell Regenerative Medicine, Inc.?
The date of the name change from Organicell Regenerative Medicine, Inc. was June 25, 2018.
What is the SIC code for Zeo ScientifiX, Inc.?
The Standard Industrial Classification (SIC) code for Zeo ScientifiX, Inc. is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Stats: 511 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-11-13 08:45:25
Filing Documents
- zeoscientifix_8k.htm (8-K) — 34KB
- zeoscientifix_ex99-1.htm (EX-99.1) — 15KB
- 0001829126-24-007451.txt ( ) — 218KB
- ocel-20241113.xsd (EX-101.SCH) — 3KB
- ocel-20241113_lab.xml (EX-101.LAB) — 33KB
- ocel-20241113_pre.xml (EX-101.PRE) — 22KB
- zeoscientifix_8k_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On November 13, 2024, we issued a press release announcing that the Company's first product developed in collaboration with Exotropin, LLC (" Exotropin "), ZEO HAIR GROW Powered By Exotropin will be introduced at the Medical Aesthetics Professionals meeting being held in Scottsdale, Arizona from November 14-16, 2024. Exotropin is a privately-held developer of advanced cosmeceuticals using exosomes and other proprietary technology. ZEO holds a minority equity interest in Exotropin. A copy of the press release is attached as Exhibit 99.1 to this Report.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1* Press Release, dated November 13, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Furnished but not filed. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: November 13, 2024 ZEO SCIENTIFIX, INC. By: /s/ Ian T. Bothwell Ian T. Bothwell Interim Chief Executive Officer and Chief Financial Officer 2